학술논문
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF).
Document Type
Article
Author
Source
BMJ Open Respiratory Research; 2023, Vol. 10 Issue 1, p1-8, 8p
Subject
Language
ISSN
20524439